Jamesn Topper News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jamesn topper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jamesn Topper Today - Breaking & Trending Today

NewAmsterdam Pharma (NASDAQ:NAMS) Trading 6.7% Higher

NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) shares were up 6.7% during mid-day trading on Tuesday . The stock traded as high as $21.78 and last traded at $21.58. Approximately 22,961 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 240,353 shares. The stock had previously closed at […] ....

Jamesn Topper , Newamsterdam Pharma , Piper Sandler , Louisg Lange , Newamsterdam Pharma Company , Royal Bank , Opaleye Management Inc , Securities Exchange Commission , Yarbrough Capital , Fcpm Iii Services , Parkman Healthcare Partners , Wolverine Asset Management , Get Free Report , Director Louis , Director James , Exchange Commission , Healthcare Partners , Asset Management , Newamsterdam Pharma Daily , Nasdaq Nams ,

NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Up 6.7%

NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report)’s share price rose 6.7% during trading on Tuesday . The company traded as high as $21.78 and last traded at $21.58. Approximately 22,961 shares changed hands during trading, a decline of 90% from the average daily volume of 240,353 shares. The stock had previously closed at $20.23. Analyst […] ....

Jamesn Topper , Piper Sandler , Newamsterdam Pharma , Louisg Lange , Newamsterdam Pharma Company , Wolverine Asset Management , Newamsterdam Pharma Company Profile , Securities Exchange Commission , Opaleye Management Inc , Royal Bank , Schonfeld Strategic Advisors , Yarbrough Capital , Affinity Asset Advisors , Get Free Report , Director Louis , Exchange Commission , Director James , Asset Management , Strategic Advisors , Asset Advisors , Opaleye Management , Newamsterdam Pharma Daily , Nasdaq Nams ,

NewAmsterdam Pharma (NASDAQ:NAMS) Trading Up 2.1%

NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) shares traded up 2.1% during trading on Wednesday . The stock traded as high as $19.59 and last traded at $19.34. 58,206 shares traded hands during mid-day trading, a decline of 75% from the average session volume of 237,350 shares. The stock had previously closed at $18.95. Analysts […] ....

Piper Sandler , Newamsterdam Pharma , Jamesn Topper , Securities Exchange Commission , Geode Capital Management , Jpmorgan Chase Co , Wolverine Asset Management , Newamsterdam Pharma Company , Royal Bank , Schonfeld Strategic Advisors , Get Free Report , Director James , Exchange Commission , Johannes Jacob Piete Kastelein , Asset Management , Capital Management , Strategic Advisors , Newamsterdam Pharma Daily , Nasdaq Nams ,

NewAmsterdam Pharma (NASDAQ:NAMS) Shares Up 2.1%

NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) shares were up 2.1% on Wednesday . The stock traded as high as $19.59 and last traded at $19.34. Approximately 58,206 shares changed hands during trading, a decline of 75% from the average daily volume of 237,350 shares. The stock had previously closed at $18.95. Analyst Ratings Changes […] ....

Piper Sandler , Jamesn Topper , Newamsterdam Pharma , Schonfeld Strategic Advisors , Royal Bank , Jpmorgan Chase Co , Securities Exchange Commission , Geode Capital Management , Newamsterdam Pharma Company , Marshall Wace , Alyeska Investment Group , Get Free Report , Director James , Exchange Commission , Johannes Jacob Piete Kastelein , Strategic Advisors , Capital Management , Newamsterdam Pharma Daily , Nasdaq Nams ,

NewAmsterdam Pharma (NASDAQ:NAMS) Sees Unusually-High Trading Volume

NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 136,045 shares changed hands during mid-day trading, a decline of 43% from the previous session’s volume of 239,271 shares.The stock last traded at $23.06 and had previously closed at $23.65. Analyst Ratings Changes Several equities analysts recently weighed in […] ....

Newamsterdam Pharma , Jamesn Topper , Louisg Lange , Piper Sandler , Securities Exchange Commission , Goldman Sachs Group Inc , Newamsterdam Pharma Company , Parkman Healthcare Partners , Fcpm Iii Services , Royal Bank , Opaleye Management Inc , Get Free Report , Amsterdam Pharma Stock Down , Director Louis , Exchange Commission , Director James , Sachs Group , Healthcare Partners , Newamsterdam Pharma Daily ,